SCA
EMN icon

Southpoint Capital Advisors’s Eastman Chemical EMN Stock Holding History

Southpoint Capital Advisors’s Portfolio EMN Stock Details EMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-800,000
Closed -$80.2M – 52
2024
Q1 		$80.2M Buy
+800,000
New +$70.4M 1.59% 25
2022
Q1 		– Sell
-300,000
Closed -$36.3M – 53
2021
Q4 		$36.3M Buy
+300,000
New +$33.4M 0.7% 35

Other funds holding EMN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Southpoint Capital Advisors's EMN Position: Q2 2024 in Review

Southpoint Capital Advisors sold out of Eastman Chemical (EMN) in Q2 2024, closing a stake of 800,000 shares — an estimated $80.2M sold.

Southpoint Capital Advisors first reported a position in EMN in Q4 2021 and held it in 2 quarters. The position peaked at $80.2M in Q1 2024. 751 funds tracked by Wall St. Rank hold EMN as of Q2 2024.

  • Southpoint Capital Advisors reported no remaining Eastman Chemical position as of Q2 2024 after selling out during the quarter.
  • Southpoint Capital Advisors sold 800,000 Eastman Chemical shares in Q2 2024, an estimated $80.2M.
  • Southpoint Capital Advisors first reported a position in Eastman Chemical in Q4 2021 and held it in 2 quarters.
  • Southpoint Capital Advisors's Eastman Chemical position peaked at $80.2M in Q1 2024.
  • 751 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2024.

Based on Southpoint Capital Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.